![Keith E. Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith E. Wilson
Geen lopende functies
Profiel
Keith E.
Wilson served as the Chief Scientific Officer at Oxford BioTherapeutics Ltd.
Prior to that, he obtained a doctorate degree from Oregon Health & Science University.
Eerdere bekende functies van Keith E. Wilson
Bedrijven | Functie | Einde |
---|---|---|
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Keith E. Wilson
Oregon Health & Science University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |